Answers are grounded in this paper and cite their sources.
The aim of this study was to make solid lipid nanoparticles that are filled with donepezil so that they can be delivered to the brain through the nose.Solid lipid nanoparticles were made using a surfactant mix of tween 80 and poloxamer 188 and a lipid called glyceryl behenate.This was done through a liquid emulsification diffusion method.The solid lipid nanoparticles were tested for their stability, drug release in vitro, zeta potential, particle size, and their ability to work in living things.We found that the improved version released 96.72 ± 5.89% of the drug in vitro in 24 h.The Higuchi model fit the data the best, with an r 2 value of 0.9504.The best mixture of solid lipid nanoparticles containing donepezil was kept at 4±2 °C (refrigerator) and 25±2 °C/60 ±5% RH for up to six months.Stability studies showed that there were no major changes in the mixture's zeta potential, drug loading, or ability to entrap other molecules.When the improved mixture was kept at 40±2 °C and 75±5% RH, however, the particles got a lot bigger.It seems that the optimized formulation is better at hitting the brain than other formulations because it has higher drug targeting efficiency and direct transfer %.
No takes yet. Share an insight, caveat, or question.
Rajapandi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: